US Patent Issued to AELIS FARMA, INSERM (Institut National de la Sante et de la Recherche Medicale), UNIVERSITE DE BORDEAUX on Oct. 21 for "3Beta-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of Cannabinoids-Related Disorders" (French Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,159, issued on Oct. 21, was assigned to AELIS FARMA (Bordeaux, France), INSERM (Institut National de la Sante et de la Recherche Medicale) (Paris) and UNIVERSITE DE BORDEAUX (Bordeaux, France).

"3Beta-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of Cannabinoids-Related Disorders" was invented by Pier Vincenzo Piazza (Bordeaux, France), Sandy Fabre (Bordeaux, France), Mathilde Metna (Bordeaux, France), Stephanie Monlezun (Bordeaux, France), Arnau Busquet-Garcia (Bordeaux, France), Daniela Cota (Bordeaux, France), Giovanni Marsicano (Bordeaux, France), Jean-Michel Revest (Bordeaux, France) and Monique Vallee (Bordeaux, France).

According to the abstract* released ...